Nkarta (NKTX) News Today → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free NKTX Stock Alerts $6.25 -0.05 (-0.79%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNkarta (NASDAQ:NKTX) PT Lowered to $15.00marketbeat.com - May 10 at 7:28 PMNkarta Inc (NKTX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Analysisfinance.yahoo.com - May 10 at 5:10 PMNkarta, Inc.: Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlightsfinanznachrichten.de - May 10 at 12:10 PMNkarta Inc. Buy Rating Affirmed Amidst Promising Clinical Studies and Robust Financial Healthmarkets.businessinsider.com - May 10 at 12:10 PMBuy Rating Affirmed: Nkarta’s NKX019 Shows Promise in Lupus Nephritis Clinical Trialsmarkets.businessinsider.com - May 10 at 12:10 PMNKTX Stock Earnings: Nkarta Beats EPS for Q1 2024investorplace.com - May 10 at 12:09 AMNkarta Reports First Quarter 2024 Financial Results and Corporate Highlightsfinance.yahoo.com - May 9 at 4:08 PMNkarta Reports First Quarter 2024 Financial Results and Corporate Highlightsglobenewswire.com - May 9 at 4:01 PMOpportunity Alert: 3 Undiscovered Stocks About to Explode on Wall Street's Radarinvestorplace.com - May 7 at 6:30 AMAmgen’s Blincyto data send Cullinan highermsn.com - April 27 at 4:40 PMNkarta: Down 50% Since March With A Clinical Catalyst Aheadseekingalpha.com - April 27 at 11:40 AMNkarta, Inc. (NKTX) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - April 18 at 8:03 PMAnalysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Nkarta (NKTX)markets.businessinsider.com - April 10 at 2:40 PMAnalysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Arcutis Biotherapeutics (ARQT)markets.businessinsider.com - April 10 at 9:39 AMNeedham & Company LLC Reiterates Buy Rating for Nkarta (NASDAQ:NKTX)marketbeat.com - April 10 at 8:17 AMGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investorsbusinesswire.com - April 8 at 12:55 PMINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investorsbusinesswire.com - April 5 at 5:44 PMThe Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investorsbusinesswire.com - April 5 at 3:35 PMNkarta to Participate in Upcoming Investor Conferencesglobenewswire.com - April 3 at 4:02 PMNkarta (NASDAQ:NKTX) Stock Price Down 5.7%marketbeat.com - April 2 at 12:50 PMNkarta (NASDAQ:NKTX) Shares Gap Up to $10.81marketbeat.com - April 1 at 11:59 AMHuge Insider Buying From Buffett, an NFL Team Owner, a New CEO247wallst.com - March 31 at 8:55 AMSimeon George Purchases 2,000,000 Shares of Nkarta, Inc. (NASDAQ:NKTX) Stockinsidertrades.com - March 30 at 4:16 AMNkarta, Inc. (NASDAQ:NKTX) Director Acquires $20,000,000.00 in Stockmarketbeat.com - March 28 at 7:21 PMTD Cowen Reaffirms Their Buy Rating on Nkarta (NKTX)markets.businessinsider.com - March 27 at 5:39 AMPromising Biopharma Nkarta (NASDAQ:NKTX) Not For the Faint-Heartedmsn.com - March 27 at 5:39 AMNkarta (NASDAQ:NKTX) Price Target Increased to $16.00 by Analysts at Canaccord Genuity Groupmarketbeat.com - March 26 at 8:47 AMNkarta, Inc. (NKTX) interactive stock chart – Yahoo Financesg.finance.yahoo.com - March 26 at 8:34 AMNkarta: NK Cell Therapy Advancement On Two Frontsseekingalpha.com - March 25 at 5:33 PMNkarta announces pricing of stock offering to raise $240.1Mmsn.com - March 25 at 12:32 PMNkarta Prices $240 Mln Offering; Stock Up Over 16%markets.businessinsider.com - March 25 at 7:32 AMNkarta Announces Pricing of $240 Million Underwritten Offeringglobenewswire.com - March 25 at 6:30 AMNkarta’s Strategic Pivot to CAR-NK Therapies for Autoimmune Diseases Prompts Buy Ratingmarkets.businessinsider.com - March 25 at 2:30 AMNkarta Inc (NKTX) Posts Full Year 2023 Financial Results: A Focus on NKX019 and Pipeline Realignmentfinance.yahoo.com - March 23 at 8:09 AMNkarta, Inc.: Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlightsfinanznachrichten.de - March 22 at 12:05 PMBuy Rating for Nkarta: Promising Future for NKX019 in Autoimmune Disease Treatmentmarkets.businessinsider.com - March 22 at 12:05 PMNkarta’s Strategic Focus and Financial Strength Underpin Buy Ratingmarkets.businessinsider.com - March 22 at 12:05 PMThese Analysts Revise Their Forecasts On Nkarta After Q4 Resultsmsn.com - March 22 at 12:05 PMNkarta (NASDAQ:NKTX) Given New $25.00 Price Target at Mizuhomarketbeat.com - March 22 at 11:45 AMmarketbeat.com - March 22 at 9:37 AMNkarta (NASDAQ:NKTX) Receives Outperform Rating from Raymond Jamesmarketbeat.com - March 22 at 8:17 AMNKTX Stock Earnings: Nkarta Beats EPS for Q4 2023investorplace.com - March 21 at 11:02 PMNkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlightsglobenewswire.com - March 21 at 4:01 PMNkarta (NASDAQ:NKTX) Stock Price Up 8.4%marketbeat.com - March 19 at 3:57 PMInnovative NK-Cell Therapy: A Buy Rating for Nkarta’s Groundbreaking Approach to Autoimmune Diseasesmarkets.businessinsider.com - March 19 at 8:06 AM3 Overlooked Stocks Ready to Capture the Market by Storminvestorplace.com - March 19 at 7:29 AMNKTX Apr 2024 30.000 callfinance.yahoo.com - March 18 at 5:03 PMNKTX Apr 2024 17.500 putfinance.yahoo.com - March 16 at 7:34 PMNKTX Apr 2024 10.000 callfinance.yahoo.com - March 16 at 7:34 PMNKTX May 2024 25.000 callfinance.yahoo.com - March 16 at 9:32 AM Get Nkarta News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… NKTX Media Mentions By Week NKTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NKTX News Sentiment▼0.060.58▲Average Medical News Sentiment NKTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NKTX Articles This Week▼132▲NKTX Articles Average Week Get Nkarta News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Atai Life Sciences News Today Precigen News Today Terns Pharmaceuticals News Today UroGen Pharma News Today Rani Therapeutics News Today Neoleukin Therapeutics News Today Heron Therapeutics News Today Atea Pharmaceuticals News Today Organogenesis News Today FibroBiologics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NKTX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithMost important medical advance in 100 yearsThe Oxford ClubA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchMissed NVDA? Buy this AI stock NOWChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nkarta, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
